Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
Public ClinicalTrials.gov record NCT03727100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multicenter, Randomized, Double-Blinded, Sham-Control Study to Evaluate the Efficacy and Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety and effectiveness of a new pain medication in development, clonidine micropellet. Participants will receive a single injection of either clonidine micropellet or sham injection for the treatment of low back and leg pain from sciatica.
Study identification
- NCT ID
- NCT03727100
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 207 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 16, 2018 (Actual)
- Primary completion
- Mar 5, 2020 (Actual)
- Completion
- Jul 18, 2020 (Actual)
- Last update posted
- Oct 6, 2023
2018 – 2020
United States locations
- U.S. sites
- 33
- U.S. states
- 19
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sollis Clinical Study Site 36 | Mobile | Alabama | 36605 | — |
| Sollis Clinical Study Site #41 | Phoenix | Arizona | 85018 | — |
| Sollis Clinical Study Site #44 | Phoenix | Arizona | 85053 | — |
| Sollis Clinical Study Site 29 | Scottsdale | Arizona | 85258 | — |
| Sollis Clinical Study Site 40 | Tucson | Arizona | 85724 | — |
| Sollis Clinical Study Site 49 | Rancho Mirage | California | 92270 | — |
| Sollis Clinical Study Site 28 | Santa Rosa | California | 95401 | — |
| Sollis Clinical Study Site 30 | Washington D.C. | District of Columbia | 22205 | — |
| Sollis Clinical Study Site 35 | Fort Lauderdale | Florida | 33316 | — |
| Sollis Clinical Study Site 38 | Miami | Florida | 33135 | — |
| Sollis Clinical Study Site 12 | Bloomington | Illinois | 61704 | — |
| Sollis Clinical Study Site 13 | Chicago | Illinois | 60657 | — |
| Sollis Clinical Study Site 14 | Kansas City | Kansas | 66160 | — |
| Sollis Clinical Study Site | Overland Park | Kansas | 66210 | — |
| Sollis Clinical Study Site 10 | Edgewood | Kentucky | 41017 | — |
| Sollis Clinical Study Site 16 | Boston | Massachusetts | 02115 | — |
| Sollis Clinical Study Site 15 | Brookline | Massachusetts | 02445 | — |
| Sollis Clinical Study Site 17 | Shrewsbury | New Jersey | 60657 | — |
| Sollis Clinical Study Site 25 | Albany | New York | 12208 | — |
| Sollis Clinical Study Site 31 | Rochester | New York | 14620 | — |
| Sollis Clinical Study Site 18 | Winston-Salem | North Carolina | 27103 | — |
| Sollis Clinical Study Site 21 | Cleveland | Ohio | 44106 | — |
| Sollis Clinical Study Site 33 | Cleveland | Ohio | 44195 | — |
| Sollis Clinical Study Site 19 | Edmond | Oklahoma | 73013 | — |
| Sollis Clinical Study Site 46 | Eugene | Oregon | 97401 | — |
| Sollis Clinical Study Site | Dallas | Texas | 75240 | — |
| Sollis Clinical Study Site 34 | Houston | Texas | 77004 | — |
| Sollis Clinical Study Site 22 | San Antonio | Texas | 78229 | — |
| Sollis Clinical Study Site 43 | The Woodlands | Texas | 77382 | — |
| Sollis Clinical Study Site 20 | Tyler | Texas | 75701 | — |
| Sollis Clinical Study Site 47 | Salt Lake City | Utah | 84107 | — |
| Sollis Clinical Study Site 23 | Morgantown | West Virginia | 26505 | — |
| Sollis Clinical Study Site 27 | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03727100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2023 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03727100 live on ClinicalTrials.gov.